Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Which somatic symptoms are associated with an unfavorable course in Chinese patients with major depressive disorder?

Novick D, Montgomery WS, Aguado J, Peng X, Brugnoli R, Haro JM.

Asia Pac Psychiatry. 2015 Jun 5. doi: 10.1111/appy.12189. [Epub ahead of print]

PMID:
26047023
2.

Chinese patients with major depression: Do concomitant pain symptoms affect quality of life independently of severity of depression?

Novick D, Montgomery W, Moneta MV, Peng X, Brugnoli R, Haro JM.

Int J Psychiatry Clin Pract. 2015 May 7:1-8. [Epub ahead of print]

PMID:
25946899
3.

Mitochondrial myopathy and comorbid major depressive disorder: effectiveness of dTMS on gait and mood symptoms.

Rapinesi C, Janiri D, Kotzalidis GD, Serata D, Del Casale A, Scatena P, Dacquino C, Gentile G, Manfredi G, Danese E, Raccah RN, Brugnoli R, Callovini G, Ferri VR, Ferracuti S, Zangen A, Simmaco M, Angeletti G, Girardi P.

Gen Hosp Psychiatry. 2015 May-Jun;37(3):274.e7-9. doi: 10.1016/j.genhosppsych.2015.03.002. Epub 2015 Mar 13.

PMID:
25799088
4.

Antidepressant medication treatment patterns in Asian patients with major depressive disorder.

Novick D, Montgomery W, Moneta V, Peng X, Brugnoli R, Haro JM.

Patient Prefer Adherence. 2015 Mar 11;9:421-8. doi: 10.2147/PPA.S68432. eCollection 2015.

5.

Are 5-HT3 antagonists effective in obsessive-compulsive disorder? A systematic review of literature.

Serata D, Kotzalidis GD, Rapinesi C, Janiri D, Di Pietro S, Callovini G, Piacentino D, Gasperoni C, Brugnoli R, Ferri VR, Girardi N, Tatarelli R, Ferracuti S, Angeletti G, Girardi P, Del Casale A.

Hum Psychopharmacol. 2015 Mar;30(2):70-84. doi: 10.1002/hup.2461. Epub 2015 Feb 10.

PMID:
25676060
6.

Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists.

Fagiolini A, Brugnoli R, Di Sciascio G, De Filippis S, Maina G.

Expert Opin Pharmacother. 2015 Apr;16(5):727-37. doi: 10.1517/14656566.2015.1013029. Epub 2015 Feb 12.

PMID:
25672664
7.

Impact of painful physical symptoms on depression outcomes in elderly Asian patients.

Novick D, Montgomery W, Bertsch J, Peng X, Brugnoli R, Haro JM.

Int Psychogeriatr. 2014 Nov 4:1-8. [Epub ahead of print]

PMID:
25366979
8.

The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia.

Galderisi S, Rossi A, Rocca P, Bertolino A, Mucci A, Bucci P, Rucci P, Gibertoni D, Aguglia E, Amore M, Bellomo A, Biondi M, Brugnoli R, Dell'Osso L, De Ronchi D, Di Emidio G, Di Giannantonio M, Fagiolini A, Marchesi C, Monteleone P, Oldani L, Pinna F, Roncone R, Sacchetti E, Santonastaso P, Siracusano A, Vita A, Zeppegno P, Maj M; Italian Network For Research on Psychoses.

World Psychiatry. 2014 Oct;13(3):275-87. doi: 10.1002/wps.20167.

9.

Alcohol and suicidality: could deep transcranial magnetic stimulation (dTMS) be a possible treatment?

Rapinesi C, Kotzalidis GD, Scatena P, Del Casale A, Janiri D, Callovini G, Piacentino D, Serata D, Raccah RN, Brugnoli R, Digiacomantonio V, Mascioli F, Ferri VR, Ferracuti S, Pompili M, De Pisa E, Di Pietro S, Zangen A, Angeletti G, Girardi P.

Psychiatr Danub. 2014 Sep;26(3):281-4. No abstract available.

10.

Add-on deep transcranial magnetic stimulation (dTMS) in patients with dysthymic disorder comorbid with alcohol use disorder: a comparison with standard treatment.

Girardi P, Rapinesi C, Chiarotti F, Kotzalidis GD, Piacentino D, Serata D, Del Casale A, Scatena P, Mascioli F, Raccah RN, Brugnoli R, Digiacomantonio V, Ferri VR, Ferracuti S, Zangen A, Angeletti G.

World J Biol Psychiatry. 2015 Jan;16(1):66-73. doi: 10.3109/15622975.2014.925583. Epub 2014 Aug 20.

PMID:
25140585
11.

[Phenelzine: legacy or current psychiatric practice?].

Marini S, Serata D, Brugnoli R.

Clin Ter. 2013 May-Jun;164(3):e211-22. doi: 10.7417/CT.2013.1571. Review. Italian.

PMID:
23868641
12.

Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?

Novick D, Montgomery W, Kadziola Z, Moneta V, Peng X, Brugnoli R, Haro JM.

Patient Prefer Adherence. 2013 May 27;7:463-70. doi: 10.2147/PPA.S41703. Print 2013.

13.

Changes in adherence and treatment costs following initiation of oral or depot typical antipsychotics among previously non-adherent patients with schizophrenia.

Hong J, Novick D, Brugnoli R, Bertsch J, Haro JM.

Hum Psychopharmacol. 2013 Sep;28(5):438-46. doi: 10.1002/hup.2328. Epub 2013 Jun 15.

PMID:
23775950
14.

Efficacy of add-on deep transcranial magnetic stimulation in comorbid alcohol dependence and dysthymic disorder: three case reports.

Rapinesi C, Kotzalidis GD, Serata D, Del Casale A, Bersani FS, Solfanelli A, Scatena P, Raccah RN, Brugnoli R, Digiacomantonio V, Carbonetti P, Fensore C, Tatarelli R, Angeletti G, Ferracuti S, Girardi P.

Prim Care Companion CNS Disord. 2013;15(1). pii: PCC.12m01438. doi: 10.4088/PCC.12m01438. Epub 2012 Feb 7.

15.

Which somatic symptoms are associated with an unfavorable course in Asian patients with major depressive disorder?

Novick D, Montgomery W, Aguado J, Kadziola Z, Peng X, Brugnoli R, Haro JM.

J Affect Disord. 2013 Jul;149(1-3):182-8. doi: 10.1016/j.jad.2013.01.020. Epub 2013 Mar 19.

PMID:
23521872
16.

Depressive pseudodementia in the elderly: effectiveness of electroconvulsive therapy.

Rapinesi C, Serata D, Del Casale A, Kotzalidis GD, Mazzarini L, Fensore C, Carbonetti P, Scatena P, Capezzuto S, Moscati FM, Brugnoli R, Tatarelli R, Girardi P.

Int J Geriatr Psychiatry. 2013 Apr;28(4):435-8. doi: 10.1002/gps.3877. No abstract available.

PMID:
23468198
17.

Effectiveness of short-term olanzapine in patients with bipolar I disorder, with or without comorbidity with substance use disorder.

Sani G, Kotzalidis GD, Vöhringer P, Pucci D, Simonetti A, Manfredi G, Savoja V, Tamorri SM, Mazzarini L, Pacchiarotti I, Telesforo CL, Ferracuti S, Brugnoli R, Ambrosi E, Caloro M, Del Casale A, Koukopoulos AE, Vergne DE, Girardi P, Ghaemi SN.

J Clin Psychopharmacol. 2013 Apr;33(2):231-5. doi: 10.1097/JCP.0b013e318287019c.

PMID:
23422396
18.

Emotion recognition impairment is present early and is stable throughout the course of schizophrenia.

Comparelli A, Corigliano V, De Carolis A, Mancinelli I, Trovini G, Ottavi G, Dehning J, Tatarelli R, Brugnoli R, Girardi P.

Schizophr Res. 2013 Jan;143(1):65-9. doi: 10.1016/j.schres.2012.11.005. Epub 2012 Dec 4.

PMID:
23218561
19.
20.

Duloxetine in the treatment of elderly people with major depressive disorder.

Del Casale A, Girardi P, Brugnoli R, Sani G, Di Pietro S, Brugnoli C, Caccia F, Angeletti G, Serata D, Rapinesi C, Tatarelli R, Kotzalidis GD.

Riv Psichiatr. 2012 Nov-Dec;47(6):479-88. doi: 10.1708/1178.13054. Review.

PMID:
23160108
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk